BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15152776)

  • 1. [Severe fatigue in cancer. Causes from A as anemia to Z as cytostatics].
    MMW Fortschr Med; 2004 Mar; 146(11):57. PubMed ID: 15152776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anemia and cancer].
    Cappelaere P
    Bull Cancer; 2003 Apr; 90 Spec No():S117-8. PubMed ID: 12861965
    [No Abstract]   [Full Text] [Related]  

  • 3. No rest for fatigue researchers.
    McNeil C
    J Natl Cancer Inst; 2008 Aug; 100(16):1129-31. PubMed ID: 18695127
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients.
    Lawrence DP; Kupelnick B; Miller K; Devine D; Lau J
    J Natl Cancer Inst Monogr; 2004; (32):40-50. PubMed ID: 15263040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin therapy in cancer-related anaemia, yes or no?
    Herrmann R
    Intern Med J; 2008 Oct; 38(10):749-50. PubMed ID: 19143876
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Anand A; Anand A; Anand N
    Cancer; 1996 May; 77(9):1960-1. PubMed ID: 8646701
    [No Abstract]   [Full Text] [Related]  

  • 7. EPO in cancer anemia: benefits and potential risks.
    Milano M; Schneider M
    Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatigue--when cancer patients are consistently without drive and energy. Determine the etiology!].
    Weigang-Köhler K
    MMW Fortschr Med; 2003 Mar; 145(11):30-4. PubMed ID: 12688192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and application of anemia clinical practice guidelines.
    Winn RJ; Muller RJ; Cella D
    J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-33-9. PubMed ID: 23573552
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence-based treatment for cancer-related fatigue.
    Mock V
    J Natl Cancer Inst Monogr; 2004; (32):112-8. PubMed ID: 15263051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concern about the safety of erythropoietin in cancer patients].
    van der Lelie J
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):920-2. PubMed ID: 18561786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. My get up and go got up and went: fatigue in people with cancer.
    Nail LM
    J Natl Cancer Inst Monogr; 2004; (32):72-5. PubMed ID: 15263043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anemia impact on treatments of cervical carcinomas].
    Marchal C; Rangeard L; Brunaud C
    Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom control trials: a 20-year experience.
    Loprinzi CL; Barton DL; Jatoi A; Sloan J; Martenson J; Steensma D; Rao R; Novotny P; Sood A; Grothey A; Minasian L; Windschitl H
    J Support Oncol; 2007 Mar; 5(3):119-25, 128. PubMed ID: 17410810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. If only it were simple.
    Winn RJ
    J Natl Compr Canc Netw; 2005 Nov; 3(6):731. PubMed ID: 16316610
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatigue in cancer patients].
    Höckel M; Wilmer A; Jaehde U
    Med Monatsschr Pharm; 2012 May; 35(5):172-9; quiz 181-2. PubMed ID: 22624351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care of the patient with cancer.
    Smith GF; Toonen TR
    Am Fam Physician; 2007 Apr; 75(8):1207-14. PubMed ID: 17477104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia: cancer patients who are very likely to benefit often go untreated.
    J Support Oncol; 2003; 1(1):68. PubMed ID: 15352647
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic use of erythropoietin in dermatooncology.
    Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.